Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zevra Therapeutics (ZVRA) Amortization - Intangibles: 2023-2024

Historic Amortization - Intangibles for Zevra Therapeutics (ZVRA) over the last 2 years, with Dec 2024 value amounting to $6.2 million.

  • Zevra Therapeutics' Amortization - Intangibles fell 79.61% to $315,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 4.25%. This contributed to the annual value of $6.2 million for FY2024, which is 707.64% up from last year.
  • According to the latest figures from FY2024, Zevra Therapeutics' Amortization - Intangibles is $6.2 million, which was up 707.64% from $772,000 recorded in FY2023.
  • Zevra Therapeutics' 5-year Amortization - Intangibles high stood at $6.2 million for FY2024, and its period low was $772,000 during FY2023.
  • For the 2-year period, Zevra Therapeutics' Amortization - Intangibles averaged around $3.5 million, with its median value being $3.5 million (2023).
  • Data for Zevra Therapeutics' Amortization - Intangibles shows a peak YoY soared of 707.64% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zevra Therapeutics' Amortization - Intangibles stood at $772,000 in 2023, then soared by 707.64% to $6.2 million in 2024.